News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioProcess Technology Consultants, Inc. Appoints Wells as Senior Consultant



9/16/2013 9:51:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WOBURN, MASSACHUSETTS, September 16, 2013— Bioprocess Technology Consultants, Inc. (BPTC), the leading strategic, technical, and regulatory consulting company for the global biopharmaceutical industry, has appointed Keith H. Wells, Ph.D., as a Senior Consultant.

Dr. Wells joins BPTC after 13 years at Biologics Consulting Group (BCG), where he was Senior Consultant and New England Office Head. He consulted for a range of clients including government agencies, non-governmental organizations, small virtual companies, and multinational biopharmaceutical corporations.

“We are excited to bring such a talented manufacturing and process development expert to the team and to supplement our expertise in the area of vaccines and medical countermeasures for biological defense,” said Howard L. Levine, Ph.D., President of BPTC. “Clients will benefit from Keith’s knowledge about design, validation, and operation of biological manufacturing facilities, as well as his valuable experience in the preparation and filing of regulatory submissions in the US and abroad.”

Before BCG, Dr. Wells was Senior Director, Manufacturing and Process Development, of Acambis, where he directed process development, process validation, and manufacturing for all vaccine and immune globulin products. Previously, he was Director of Vaccine Production and Product Development at the Salk Institute Government Services Division. There he headed process development, validation, and manufacturing in a multiuse, biological safety level 3 facility for both government and private clients. Before that, he was Research Fellow in Biological Process Research and Development at Merck and Company. His responsibilities included process development and optimization, culture medium development, and process scale-up for human vaccine and gene therapy products.

Involved with the development of numerous vaccines against emerging diseases and biological threat agents, he is a member of the steering committee for the DARPA/UPMC 21st Century Biodefense Advanced Development and Manufacturing of Biological Countermeasures effort.

He received his B.A. (cum laude) in Microbiology from the University of Texas at Austin, and his Ph.D. in Microbiology and Immunology from State University of New York Health Science Center at Syracuse.

About BioProcess Technology Consultants

Founded in 1994, BPTC is the recognized worldwide leader in biologics Chemistry, Manufacturing, and Controls (CMC) consulting, providing a full range of technical, regulatory, and strategic assistance to pharmaceutical and biotechnology companies in the development and commercialization of biopharmaceutical products. The company works with clients globally to find and apply solutions to the challenges of biopharmaceutical product development from clone to commercial®. BPTC helps develop manufacturing processes and strategies that enhance the overall value of client companies and accelerate the advancement of new products from clone to clinic®. BPTC also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more information about BPTC, visit http://www.bptc.com and follow the Company on Twitter at bptcGlobal or LinkedIn at http://www.linkedin.com/company/bioprocess-technology-consultants-inc.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES